Immunodiagnostic Systems Holdings PLC (“the Company”), a leading producer of diagnostic testing kits, has been informed today that the stepson of Paul Hailes, Finance Director, has sold 1,350 ordinary shares of 2p in the Company at a price of 677.15 pence. The shares were held in Paul Hailes’ name as his stepson was under the […]
Immunodiagnostic Systems Holdings PLC (“the Company”), a leading producer of diagnostic testing kits, announces that on 17 November 2009, 108,446 ordinary shares of 2p each in the Company (the “Ordinary Shares”) were allotted in a board meeting to satisfy an exercise of options. Application will be made at the earliest practicable opportunity for admission of […]
Immunodiagnostic Systems Holdings plc (“IDS”), a leading producer of diagnostic testing kits for the clinical and research markets, announces the appointment of Dr. Patrik O Dahlén as a Non-Executive Director with immediate effect. Download Announcement
Immunodiagnostic Systems Holdings PLC (“the Company”), a leading producer of diagnostic testing kits, announces that on 9 December 2009, certain Directors exercised options over in aggregate 1,134,297 ordinary shares of 2p each in the Company (“Ordinary Shares”) and subsequently placed 505,628 ordinary shares in aggregate with a number of institutional investors. Notification was received by […]
